NASDAQ:NBTX

Nanobiotix (NBTX) News Today

$4.94

-0.24 (-4.63%)

(As of 06/7/2023 ET)

Compare

Today's Range: $4.94
▼
$5.41
50-Day Range: $1.98
▼
$6.68
52-Week Range: $1.75
▼
$7.76

Volume: 52,866 shs
Average Volume: 538,846 shs
Market Capitalization: $172.31 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Institutional Ownership Headlines SEC Filings Short Interest Social Media

Get Nanobiotix News Delivered to You Automatically

NBTX Media Mentions By Week

NBTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NBTX
News Sentiment
▼
-0.54

0.51
▲
Average
Medical
News Sentiment

NBTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NBTX Articles
This Week
▼
2

1
▲
NBTX Articles
Average Week

Source

Source	Headline
	Nanobiotix: A Promising Cancer Treatment But A Risky Investment For Now msn.com - June 6 at 8:35 AM
	Pre-market Movers: AGBA, QSG, AI, OKTA, AULT… markets.businessinsider.com - June 1 at 9:44 AM
	Nanobiotix S.A.: NANOBIOTIX Provides First Quarter 2023 Operational and Financial Update finanznachrichten.de - May 18 at 9:35 AM
	Nanobiotix reports Q1 results msn.com - May 17 at 7:21 PM
	NANOBIOTIX Provides First Quarter 2023 Operational and Financial Update finance.yahoo.com - May 17 at 7:21 PM
	IBRX, TRUP and BAK among mid-day movers seekingalpha.com - May 5 at 5:09 PM
	Nanobiotix Stock Triples In Trading Session: What's Going On With Stock On Friday finance.yahoo.com - May 5 at 5:09 PM
	Nanobiotix Surges On Nearing A Contract Deal With A Major Pharma Co. markets.businessinsider.com - May 5 at 12:08 PM
	Nanobiotix Soars on Potential Tie-Up with a Healthcare Major for Lead Candidate msn.com - May 5 at 12:08 PM
	marketbeat.com - May 5 at 11:46 AM
	NANOBIOTIX Entering Final Contract Negotiations Following Agreement to Non-Binding Term Sheet for Development and Commercialization of NBTXR3 With a Major Global Pharmaceutical Company finance.yahoo.com - May 5 at 2:07 AM
	Why Are Nanobiotix Shares Plummeting Today? msn.com - April 25 at 5:22 PM
	Nanobiotix shares are trading lower after the company reported full year 2022 financial results. benzinga.com - April 25 at 12:22 PM
	NANOBIOTIX Provides Business Update and Reports Full Year 2022 Financial Results tmcnet.com - April 24 at 10:55 PM
	marketbeat.com - April 24 at 10:36 AM
	Earnings Scheduled For April 24, 2023 msn.com - April 24 at 7:54 AM
	NANOBIOTIX to Provide Operational Update and Report Full Year 2022 Financial Results on April 24, 2023 finance.yahoo.com - April 17 at 8:50 PM
	Nanobiotix S.A. (NANO.PA) uk.finance.yahoo.com - March 31 at 11:54 PM
	Nanobiotix Stock (NASDAQ:NBTX), Dividends benzinga.com - March 30 at 3:07 PM
	Nanobiotix postpones 2022 financial results release seekingalpha.com - March 29 at 7:37 PM
	Nanobiotix to Postpone Full Year 2022 Financial Results and Conference Call finance.yahoo.com - March 27 at 6:07 PM
	Nanobiotix (NBTX) to Release Quarterly Earnings on Tuesday americanbankingnews.com - March 27 at 1:26 AM
	Nanobiotix to Provide Operational Update and Report Full Year 2022 Financial Results on March 28, 2023 finance.yahoo.com - March 14 at 9:13 PM
	marketbeat.com - January 6 at 3:31 PM
	marketbeat.com - January 6 at 3:21 PM
	marketbeat.com - December 30 at 2:05 PM
	Nanobiotix randomizes 1st patient in US in phase 3 head/neck cancer trial msn.com - December 27 at 8:40 AM
	NANOBIOTIX Announces First Patient Randomized in the United States in Global Phase 3 Pivotal Trial Evaluating Radioenhancer NBTXR3 in Head and Neck Cancer finance.yahoo.com - December 27 at 8:40 AM
	NANOBIOTIX Announces Termination of Liquidity Contract and Publishes End of Contract Statement finance.yahoo.com - December 21 at 6:52 PM
	Voting Rights and Shares Capital of the Company finance.yahoo.com - December 8 at 8:18 PM
	marketbeat.com - November 30 at 4:00 PM
	marketbeat.com - November 29 at 12:51 PM
	marketbeat.com - November 22 at 3:51 PM
	NANOBIOTIX to Present at the 5th Annual Evercore ISI HealthCONx Conference finance.yahoo.com - November 15 at 6:39 PM
	NANOBIOTIX Announces Recommended Phase 2 Dose for NBTXR3 in Pancreatic Cancer finance.yahoo.com - November 14 at 6:53 PM
	Nanobiotix S.A.: NANOBIOTIX Provides Third Quarter 2022 Operational and Financial Update finanznachrichten.de - November 10 at 6:04 PM
	Nanobiotix Posts Updated Data For Radiotherapy-Activated Cancer Therapy In Head & Neck Cancer Patients finance.yahoo.com - November 10 at 6:04 PM
	NANOBIOTIX Reports Updated Phase 1 Anti-PD-1 Combination Data That May Support the Immune Stimulation Potential of Radioenhancer NBTXR3 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer finance.yahoo.com - November 10 at 5:35 AM
	NANOBIOTIX Provides Third Quarter 2022 Operational and Financial Update finance.yahoo.com - November 9 at 7:34 PM
	NANOBIOTIX Voting Rights and Shares Capital of the Company finance.yahoo.com - November 8 at 6:31 PM
	NANOBIOTIX Appoints Renowned Global Experts to Comprehensive Scientific Advisory Board for Potential First-in-Class Radioenhancer NBTXR3 finance.yahoo.com - November 2 at 9:18 PM
	NANOBIOTIX to Present at the Jefferies London Healthcare Conference finance.yahoo.com - November 1 at 11:30 AM
	NANOBIOTIX to Announce Third Quarter 2022 Financial Results on November 9, 2022 finance.yahoo.com - October 27 at 4:58 PM
	NANOBIOTIX Executes Definitive Agreement to Restructure Existing Loan With the European Investment Bank finance.yahoo.com - October 18 at 5:27 PM
	Nanobiotix Provides Business Update and Reports Financial Results for the First Half of 2022 finance.yahoo.com - September 28 at 7:19 PM
	Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022 finance.yahoo.com - September 23 at 10:54 AM
	Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial finance.yahoo.com - September 22 at 2:25 PM
	Nanobiotix Establishes Recommended Dose for Planned Registrational Study Evaluating NBTXR3 Plus Anti-PD-1 for Patients With Metastatic Head and Neck Cancer Resistant to Prior Immunotherapy finance.yahoo.com - September 21 at 5:56 PM
	Nanobiotix agrees in principle to restructure debt obligations with EU's investment bank seekingalpha.com - September 14 at 9:59 PM
	Nanobiotix Announces Agreement in Principle to Restructure Existing Loan Agreement With European Investment Bank, Extending Operating Runway Into Q1 2024 finance.yahoo.com - September 12 at 5:15 AM

Get Nanobiotix News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:NBTX) was last updated on 6/7/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Nanobiotix (NBTX) News Today

NBTX Media Mentions By Week

NBTX Media Sentiment

NBTX News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info